BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16000002)

  • 1. The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination.
    Appendino G; Daddario N; Minassi A; Moriello AS; De Petrocellis L; Di Marzo V
    J Med Chem; 2005 Jul; 48(14):4663-9. PubMed ID: 16000002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential.
    Appendino G; De Petrocellis L; Trevisani M; Minassi A; Daddario N; Moriello AS; Gazzieri D; Ligresti A; Campi B; Fontana G; Pinna C; Geppetti P; Di Marzo V
    J Pharmacol Exp Ther; 2005 Feb; 312(2):561-70. PubMed ID: 15356216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.
    Appendino G; Harrison S; De Petrocellis L; Daddario N; Bianchi F; Schiano Moriello A; Trevisani M; Benvenuti F; Geppetti P; Di Marzo V
    Br J Pharmacol; 2003 Aug; 139(8):1417-24. PubMed ID: 12922928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodinated N-acylvanillamines: potential "multiple-target" anti-inflammatory agents acting via the inhibition of t-cell activation and antagonism at vanilloid TRPV1 channels.
    Márquez N; De Petrocellis L; Caballero FJ; Macho A; Schiano-Moriello A; Minassi A; Appendino G; Muñoz E; Di Marzo V
    Mol Pharmacol; 2006 Apr; 69(4):1373-82. PubMed ID: 16394182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): The side chain benzylic methylene.
    Appendino G; Ech-Chahad A; Minassi A; De Petrocellis L; Di Marzo V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):97-9. PubMed ID: 19951840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
    Shimizu I; Iida T; Horiuchi N; Caterina MJ
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin.
    Raisinghani M; Pabbidi RM; Premkumar LS
    J Physiol; 2005 Sep; 567(Pt 3):771-86. PubMed ID: 16037081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): the homovanillyl moiety.
    Appendino G; Ech-Chahad A; Minassi A; Bacchiega S; De Petrocellis L; Di Marzo V
    Bioorg Med Chem Lett; 2007 Jan; 17(1):132-5. PubMed ID: 17046253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halogenation of 4-hydroxy-3-methoxybenzyl thiourea TRPV1 agonists showed enhanced antagonism to capsaicin.
    Kang DW; Ryu H; Lee J; Lang KA; Pavlyukovets VA; Pearce LV; Ikeda T; Lazar J; Blumberg PM
    Bioorg Med Chem Lett; 2007 Jan; 17(1):214-9. PubMed ID: 17035013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
    Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
    Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine functions as an agonist for the vanilloid receptor TRPV1.
    Pearce LV; Petukhov PA; Szabo T; Kedei N; Bizik F; Kozikowski AP; Blumberg PM
    Org Biomol Chem; 2004 Aug; 2(16):2281-6. PubMed ID: 15305207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro photo-release of a TRPV1 agonist.
    Carr JL; Wease KN; Van Ryssen MP; Paterson S; Agate B; Gallagher KA; Brown CT; Scott RH; Conway SJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):208-12. PubMed ID: 16213723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor.
    Szallasi A; Blumberg PM
    Life Sci; 1990; 47(16):1399-408. PubMed ID: 2174484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of recombinant human TRPV1 receptors expressed in SH-SY5Y human neuroblastoma cells increases [Ca(2+)](i), initiates neurotransmitter release and promotes delayed cell death.
    Lam PM; Hainsworth AH; Smith GD; Owen DE; Davies J; Lambert DG
    J Neurochem; 2007 Aug; 102(3):801-11. PubMed ID: 17442052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials.
    Kissin I; Szallasi A
    Curr Top Med Chem; 2011; 11(17):2159-70. PubMed ID: 21671878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.
    Walpole CS; Bevan S; Bovermann G; Boelsterli JJ; Breckenridge R; Davies JW; Hughes GA; James I; Oberer L; Winter J
    J Med Chem; 1994 Jun; 37(13):1942-54. PubMed ID: 8027976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin.
    Kanai Y; Hara T; Imai A
    J Pharm Pharmacol; 2006 Apr; 58(4):489-93. PubMed ID: 16597366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different vanilloid agonists cause different patterns of calcium response in CHO cells heterologously expressing rat TRPV1.
    Tóth A; Wang Y; Kedei N; Tran R; Pearce LV; Kang SU; Jin MK; Choi HK; Lee J; Blumberg PM
    Life Sci; 2005 May; 76(25):2921-32. PubMed ID: 15820503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect and relation structure-activity of nonivamide and iododerivatives in several models of lipid oxidation.
    Rosa A; Appendino G; Melis MP; Deiana M; Atzeri A; Alessandra I; Minassi A; Dessì MA
    Chem Biol Interact; 2009 Jul; 180(2):183-92. PubMed ID: 19497416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
    Seabrook GR; Sutton KG; Jarolimek W; Hollingworth GJ; Teague S; Webb J; Clark N; Boyce S; Kerby J; Ali Z; Chou M; Middleton R; Kaczorowski G; Jones AB
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1052-60. PubMed ID: 12438527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.